Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease

Background: Irisin is a myokine that regulates energy metabolism by inducing browning of adipose tissue. The aim of this study was to evaluate the relationship between irisin level and biochemical parameters of chronic kidney disease (CKD) patients in stage 2 and stage 4. Methods: The research was a...

Full description

Bibliographic Details
Main Authors: Javad Sadeghishad, Roghayeh Akbari, Durdi Qujeq, karimollah Hajian
Format: Article
Language:English
Published: Babol University of Medical Sciences 2019-06-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/article-1-1721-en.html
_version_ 1818263213514424320
author Javad Sadeghishad
Roghayeh Akbari
Durdi Qujeq
karimollah Hajian
author_facet Javad Sadeghishad
Roghayeh Akbari
Durdi Qujeq
karimollah Hajian
author_sort Javad Sadeghishad
collection DOAJ
description Background: Irisin is a myokine that regulates energy metabolism by inducing browning of adipose tissue. The aim of this study was to evaluate the relationship between irisin level and biochemical parameters of chronic kidney disease (CKD) patients in stage 2 and stage 4. Methods: The research was a cross-sectional study; the study population included patients with CKD who were over 18 years of age, included 90 individuals with CKD, of these participants, 45 were in the second stage of the CKD while the other 45 subjects were in the fourth stage. Serum irisin concentration plus the level of glucose (Glu), urea, creatinine (Cr) and hemoglobin (Hb) were measured. Results: In the present study, the serum irisin level of patients in stage 4 was significantly reduced (13.00 ng / ml) compared with patients in stage 2(21.41 ng / ml). Conclusion: With the progression of CKD from stage 2 to stage 4, parameters such as serum Cr, TG, LDL, FBS, BUN and urea levels significantly increased. Inversely, factors such as irisin, GFR, Alb, HDL and Hb levels significantly decreased. These findings suggest that irisin may be involved in the regulation of biochemical factor levels in CKD patients through the progression from stage 2 to stage 4.
first_indexed 2024-12-12T19:15:27Z
format Article
id doaj.art-22bd6dfbbe5043a58e504844c5f67763
institution Directory Open Access Journal
issn 2008-6164
2008-6172
language English
last_indexed 2024-12-12T19:15:27Z
publishDate 2019-06-01
publisher Babol University of Medical Sciences
record_format Article
series Caspian Journal of Internal Medicine
spelling doaj.art-22bd6dfbbe5043a58e504844c5f677632022-12-22T00:14:45ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722019-06-01103314319Serum Irisin level in patients undergoing different Stages of Chronic Kidney DiseaseJavad Sadeghishad0Roghayeh Akbari1Durdi Qujeq2karimollah Hajian3 Student Research Committee, Babol University of Medical Sciences, Babol, Iran Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran Cellular and Molecular Biology Research Center (CMBRC), Health Research Institute, Babol University of Medical Sciences, Babol, Iran Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Background: Irisin is a myokine that regulates energy metabolism by inducing browning of adipose tissue. The aim of this study was to evaluate the relationship between irisin level and biochemical parameters of chronic kidney disease (CKD) patients in stage 2 and stage 4. Methods: The research was a cross-sectional study; the study population included patients with CKD who were over 18 years of age, included 90 individuals with CKD, of these participants, 45 were in the second stage of the CKD while the other 45 subjects were in the fourth stage. Serum irisin concentration plus the level of glucose (Glu), urea, creatinine (Cr) and hemoglobin (Hb) were measured. Results: In the present study, the serum irisin level of patients in stage 4 was significantly reduced (13.00 ng / ml) compared with patients in stage 2(21.41 ng / ml). Conclusion: With the progression of CKD from stage 2 to stage 4, parameters such as serum Cr, TG, LDL, FBS, BUN and urea levels significantly increased. Inversely, factors such as irisin, GFR, Alb, HDL and Hb levels significantly decreased. These findings suggest that irisin may be involved in the regulation of biochemical factor levels in CKD patients through the progression from stage 2 to stage 4.http://caspjim.com/article-1-1721-en.htmlChronic kidney diseaseirisinstage
spellingShingle Javad Sadeghishad
Roghayeh Akbari
Durdi Qujeq
karimollah Hajian
Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
Caspian Journal of Internal Medicine
Chronic kidney disease
irisin
stage
title Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
title_full Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
title_fullStr Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
title_full_unstemmed Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
title_short Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
title_sort serum irisin level in patients undergoing different stages of chronic kidney disease
topic Chronic kidney disease
irisin
stage
url http://caspjim.com/article-1-1721-en.html
work_keys_str_mv AT javadsadeghishad serumirisinlevelinpatientsundergoingdifferentstagesofchronickidneydisease
AT roghayehakbari serumirisinlevelinpatientsundergoingdifferentstagesofchronickidneydisease
AT durdiqujeq serumirisinlevelinpatientsundergoingdifferentstagesofchronickidneydisease
AT karimollahhajian serumirisinlevelinpatientsundergoingdifferentstagesofchronickidneydisease